Page last updated: 2024-11-04

sulfadiazine and Heart Defects, Congenital

sulfadiazine has been researched along with Heart Defects, Congenital in 1 studies

Sulfadiazine: One of the short-acting SULFONAMIDES used in combination with PYRIMETHAMINE to treat toxoplasmosis in patients with acquired immunodeficiency syndrome and in newborns with congenital infections.
sulfadiazine : A sulfonamide consisting of pyrimidine with a 4-aminobenzenesulfonamido group at the 2-position.
diazine : The parent structure of the diazines.

Heart Defects, Congenital: Developmental abnormalities involving structures of the heart. These defects are present at birth but may be discovered later in life.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
de Groot, J1
Sloet van Oldruitenborgh-Oosterbaan, MM1
van der Linda-Sipman, JS1
Kalsbeek, HC1

Reviews

1 review available for sulfadiazine and Heart Defects, Congenital

ArticleYear
[Heart diseases in foals. A literature review exemplified by 2 case reports].
    Tijdschrift voor diergeneeskunde, 1996, Jul-01, Volume: 121, Issue:13

    Topics: Animals; Drug Combinations; Endocarditis; Heart Defects, Congenital; Heart Diseases; Horse Diseases;

1996